c8alpha
Stocks / Pharmaceuticals

MRKPharmaceuticals

Merck & Co., Inc.
$148.361d +0.1%5d +5.6%settled close · 2026-11-02

Free · no card

Get what investors say about MRK next

2 investor calls on MRK in the last 90 days (2 bullish, 0 bearish). Follow MRK free and new calls come to you in The Brief, our morning email, the day after we record them. This page shows them a week later.

or continue with Google ·

Mkt cap $367B (11/2)β 0.1152w $82–157Shares 2.47BInd. Pharmaceutical PreparationsNYSE since 1949Emp. 75,000HQ Rahway, NJmerck.com
The tape, with the calls on it

Who said what, and what MRK did next

Every dot is a day someone on the record made a call. Hover one to see who. We are not scoring them — the point is that you can see it and judge for yourself.

bullish bearish both sides
Who’s talkingIdea Scout · free

Who’s talking about MRK

5 longlatest 2026-10-22
DateVoiceStanceVenueThesis
2026-10-22Jared HolzManaging Director and Healthcare Equity Strategist, MizuhoBullishCNBC (uncut)Merck offers a more compelling way to express optimism about the cancer vaccine's prospects because its…
2026-10-22Jared HolesBullishCNBC (uncut)Merck's Keytruda cancer vaccine combination showed compelling hazard ratio data and Merck offers exposure to…
2025-11-05Bill NygrenPortfolio manager, Oakmark FundsBullishThe World According To BoyarDCF analysis of Keytruda's runoff value plus other businesses yields a price slightly above current market…
2025-09-16Bill NygrenPortfolio manager, Oakmark FundsBullishCNBC TelevisionMerck's runoff value from existing assets (Keytruda, vaccines, animal health) already exceeds the current…
2025-07-29Kevin Simpson (Capital Wealth)Founder & CIO, Capital Wealth PlanningBullishCNBC Halftime CommitteeProactive $3B cost-cutting program and pipeline diversification reduce dependence on Keytruda ahead of the…
Idea Scout tracks who’s talking across television, podcasts, and interviews — every stance dated to the appearance it came from. Sign up free →
Earnings

Last reports

No confirmed date for the next report yet.
ReportWhenEPS actual vs est.Reaction
29 Oct 2026before the open2.49 vs 2.10+3.2%
The options tape

Notable options days

Sessions in the last 120 where MRK’s settled options volume ran ≥ 2× its trailing 20-session baseline, or delta-dollar flow ran ≥ 2.5× — 9 of 120 sessions qualified.

The qualifying dates are the free record. Close, flow, call/LEAPS mix and the 20-session outcome — for every session below — are member content.
DateCloseRVOL Δ$ flow ($M)Call % LEAPS %+20 sess.
2026-10-29
2026-10-22
2026-09-14
2026-08-21
2026-08-20
2026-08-19
2026-08-06
2026-07-22
2026-06-12
+20 sess. = raw price change over the following 20 sessions — not market-adjusted; the tape tells you where to look, not what happens next.
Follow MRK and its tape leads The Brief, the free morning email, every trading day. Get The Brief — free →
The Wheel · put-selling

MRK on the Wheel

MRK passed our 1-month put test (30-delta put, 30–45 days, sold at the bid, bought back at half the credit), 2021–2026.

The Wheel lists cash-secured puts on stocks after a 3% drop, with live quotes, the chance of assignment and each stock’s own history. Free to use; a free account lets you follow stocks, add your own and ask questions.

Decision support, not advice · questions put sellers ask us

Idea Scout

Following MRK? Every Sunday we read the tape so you don't have to — who's recommending what, where they agree, and who just changed their mind. One free email a week.

Free · double opt-in · unsubscribe in one click